{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:31:53Z","timestamp":1782361913711,"version":"3.54.5"},"reference-count":22,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2013,2,1]]},"DOI":"10.3109\/09546634.2012.703308","type":"journal-article","created":{"date-parts":[[2012,6,14]],"date-time":"2012-06-14T11:52:55Z","timestamp":1339674775000},"page":"75-80","source":"Crossref","is-referenced-by-count":45,"title":["Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment"],"prefix":"10.1080","volume":"24","author":[{"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Dermatology, University of Toronto,\rToronto, Canada"},{"name":"Mediprobe Research Inc.,\rLondon, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Drummond-Main","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc.,\rLondon, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Paquet","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc.,\rLondon, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2012,7,25]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05242.x"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-008-9100-9"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0190-9622(98)70491-8","volume":"38","author":"Drake L","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2133.2000.03247.x","volume":"142","author":"Havu V","year":"2000","journal-title":"Br J Dermatol"},{"issue":"6","key":"CIT0005","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/S0190-9622(98)70492-X","volume":"38","author":"Ling MR","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-4362.1996.tb03666.x","volume":"35","author":"Montero-Gei F","year":"1996","journal-title":"Int J Dermatol"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70490-6"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000051643","volume":"202","author":"Gupta AK","year":"2001","journal-title":"Dermatology"},{"key":"CIT0009","first-page":"60","volume":"33","author":"Dourmishev L","year":"2006","journal-title":"Acta Med Bulgarica"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1097\/00007611-199512000-00006","volume":"88","author":"Smith SW","year":"1995","journal-title":"South Med J"},{"key":"CIT0011","unstructured":"European medicines agency (EMA). Questions and answers on Diflucan and associated names (fluconazole, 50, 100, 150 and 200 mg capsules, oral solution 5 mg\/ml, powder for oral suspension 10 mg\/ml or 40 mg\/ml, solution for infusion 2 mg\/ml), Outcome of a procedure under Article 30 of Directive 2001\/83\/EC. 2011. Available from http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Diflucan_30\/WC500108008.pdf.Accessed on January 31 2012."},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1159\/000018488"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)80293-9"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-008-9110-7"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199039060-00006"},{"key":"CIT0016","first-page":"352","volume":"37","author":"Laufen H","year":"1999","journal-title":"Int J Clin Pharmacol Ther"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.03.021"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.12.011"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1345\/aph.1M165","volume":"43","author":"Brown SJ","year":"2009","journal-title":"Annals Pharmacother"},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/09546630252775171","volume":"13","author":"Arca E","year":"2002","journal-title":"J Dermatolog Treat"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(09)80305-8"},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00003088-200140060-00005","volume":"40","author":"Debruyne D","year":"2001","journal-title":"Clin Pharmacoinet"}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/09546634.2012.703308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T19:02:55Z","timestamp":1661194975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/09546634.2012.703308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,25]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2,1]]}},"alternative-id":["10.3109\/09546634.2012.703308"],"URL":"https:\/\/doi.org\/10.3109\/09546634.2012.703308","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,25]]}}}